Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Times Interest Earned of 3.02 for Q2 2026, down 22087.84% on a QoQ basis from 0.01 in Q1 2026, and up 85.68% year-over-year from 1.62 in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Times Interest Earned for 18 years, with the latest figure at 3.02 in Q2 2026.
- On a quarterly basis, Times Interest Earned rose 85.68% year-over-year to 3.02 in Q2 2026; TTM through Jun 2026 was 0.21, a 84.3% decrease from a year earlier, with the FY2026 full-year figure at 13.52, up 46.24% from the prior year.
- Times Interest Earned was 3.02 for Q2 2026 at Dr Reddys Laboratories, down from 0.01 in the prior quarter.
- The five-year high for Times Interest Earned was 100.0 in Q3 2022, with the low at 50.61 in Q3 2023.
- Average Times Interest Earned over 5 years is 12.87, with a median of 20.18 recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned surged 358.86% in 2022, then slumped 390.03% in 2023.
- Over 5 years, Times Interest Earned stood at 15.1 in 2022, then sank by 190.23% to 43.82 in 2023, then soared by 47.78% to 22.89 in 2024, then surged by 100.74% to 0.17 in 2025, then slumped by 1880.21% to 3.02 in 2026.
- The last three Times Interest Earned figures came in at 3.02 (Q2 2026), 0.01 (Q1 2026), and 0.17 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.02 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | -19.31 |
| Jun 30, 2025 | -21.05 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | -22.89 |
| Sep 30, 2024 | -23.18 |
| Jun 30, 2024 | -29.97 |
| Mar 31, 2024 | -25.23 |
| Dec 31, 2023 | -43.82 |
| Sep 30, 2023 | -50.61 |
| Jun 30, 2023 | -14.33 |
| Mar 31, 2023 | -23.56 |
| Dec 31, 2022 | -15.10 |
| Sep 30, 2022 | 100.00 |
| Jun 30, 2022 | -35.19 |
| Mar 31, 2022 | -4.81 |
| Dec 31, 2021 | -26.14 |
| Sep 30, 2021 | -38.63 |